Wednesday, July 8, 2026
🇺🇸 FDA

pharma · NIKA

Anika Therapeutics S.r.l

Anika Therapeutics S.r.l.

Anika Therapeutics S.r.l patent portfolio — 69 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

HENDERSON, NV, EU HQ
Public company Type
NIKA · NYSE Ticker
Company details
Status
Public
HQ
HENDERSON, NV, EU
Programs
0
Drugs
0
Patents
69
Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Anika Therapeutics S.r.l patents

69 pharmaceutical patents indexed for Anika Therapeutics S.r.l. 5 expire within 24 months.

Anika Therapeutics S.r.l has 69 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 5 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

69 patents

Patent portfolio

Page 1 of 2

  1. US 12415779

    Processes of making 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)-benzonitrile and polymorphs thereof

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12391642

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12331026

    Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12264167

    Fused tricyclic ring derivatives as SRC homology-2 phosphate inhibitors

    Expires Mon Mar 27 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12171741

    2,3-dihydrobenzo[b]thiophene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Dec 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12077506

    Indane derivatives as hypoxia inducible factor-2(α) inhibitors

    Expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11939303

    Sulfamate derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, derivatives of 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenol, their medical use and the method of obtaining 4-(1-phenyl-1H-[1,2,3]triazol-4-yl)-phenyl sulfamate derivatives

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11753366

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors

    Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11541075

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    Expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11518772

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    Expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11459340

    Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

    Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11420936

    Hypoxia inducible factor-2(alpha) inhibitors and their use in the treatment of diseases

    Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11267782

    Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2α inhibitors

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11034705

    Fused tricyclic ring derivatives as Src homology-2 phosphate inhibitors

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10894797

    Fused tricyclic ring derivatives as SRC homology-2 phosphatase inhibitors

    Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10702628

    Hyaluronic acid derivative and neural stem cells for SCI and PNT regeneration

    Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10441677

    Methods and compositions for treating tendon degeneration

    Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10350256

    Compositions for the treatment of dermatological conditions, disorders or diseases

    Expires Mon Jul 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10215762

    Method to optimize the treatment of patients with biological drugs

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 9675655

    Compositions for the treatment of dermatological conditions, disorders or diseases

    Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8728524

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8712696

    Methods of prognosing a rheumatoid arthritis remission phenotype

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8563039

    Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions

    Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8426433

    Anticoagulant compounds, pharmaceutical compositions on their basis to treat thrombotic conditions, and plasma-substituting solution to correct hypercoagulation defects of hemodilution

    Expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8349355

    Formulations of lipoic acid and hyaluroinc acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields

    Expires Mon Jan 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8323617

    Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8304439

    Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8124120

    Crosslinked hyaluronic acid compositions for tissue augmentation

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7914990

    Methods and products for in vitro genotyping

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7829533

    Cyclosporin analog formulations

    Expires Mon Nov 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7538189

    Methods of making deuterated cyclosporin analogs

    Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7521421

    Deuterated cyclosporine analogs and methods of making the same

    Expires Mon Apr 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7429562

    Cyclosporin analog formulations

    Expires Mon Sep 25 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7358229

    Deuterated cyclosporin analogs and their use as immunomodulating agents

    Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7332472

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Feb 14 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7160867

    Rapamycin carbohydrate derivatives

    Expires Mon Jan 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7141648

    Synthesis of cyclosporin analogs

    Expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7118919

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7060672

    Cyclosporin analog formulations

    Expires Mon Jun 08 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 6998385

    Cyclosporine analogue mixtures and their use as immunomodulating agents

    Expires Mon Feb 09 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6939878

    Deuterated rapamycin compounds, method and uses thereof

    Expires Mon Sep 01 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6884429

    Medical devices incorporating deuterated rapamycin for controlled delivery thereof

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6884788

    Thiol-modified hyaluronan

    Expires Mon Apr 21 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6878550

    13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control

    Expires Mon Apr 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6780995

    Activated iododerivatives for the treatment of cancer and aids

    Expires Mon Aug 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6727227

    Tetrapetide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application

    Expires Mon Apr 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6710053

    Deuterated rapamycin compounds, method and uses thereof

    Expires Mon Mar 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6686454

    Antibodies to specific regions of cyclosporine related compounds

    Expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Anika Therapeutics S.r.l have?

69 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Anika Therapeutics S.r.l patents expire?

5 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.